Cargando…
BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma
SIMPLE SUMMARY: Ependymomas are the second most common paediatric brain tumour, and the 5-year survival rate remains no higher than 50%. Identifying new prognostic markers and targets for therapy in ependymoma is an important area of research. In this study, we demonstrate that brain lipid binding p...
Autores principales: | Sabnis, Durgagauri H., Liu, Jo-Fen, Simmonds, Lucy, Blackburn, Sophie, Grundy, Richard G., Kerr, Ian D., Coyle, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123630/ https://www.ncbi.nlm.nih.gov/pubmed/33925302 http://dx.doi.org/10.3390/cancers13092100 |
Ejemplares similares
-
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
por: Sabnis, Durgagauri H., et al.
Publicado: (2019) -
The HOPX and BLBP landscape and gliogenic regions in developing human brain
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2023) -
Expression of radial glial markers (GFAP, BLBP and GS) during telencephalic development in the catshark (Scyliorhinus canicula)
por: Docampo-Seara, A., et al.
Publicado: (2018) -
EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022) -
Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma
por: Rand, V, et al.
Publicado: (2008)